With our novel patient-reported outcome measure, PROMIS CAT, study teams can capture precise data from fewer questions or items, reducing completion burden for patients. Bonus: Incorporate it alongside traditional COAs. Get details: hubs.li/Q03pHd0z0

The placebo effect is a contributing factor in the low success rates of novel pain medication #clinicaltrials, where less than 5% of low-abuse potential drugs gain approval. See how we helped one pharma company limit placebo effect and gain FDA approval: hubs.li/Q03pXfwG0

Sites using too many systems? Our EDC offers add-on modules for eCOA, eConsent, and Randomization. One platform, one login, and happy sites. Take a look: hubs.li/Q03p_C9P0

Leading technology without limits: Global pharmaceutical leaders rely on our comprehensive #eCOA, eClinRO, and #RTSM solutions for reliable evidence generation. No surprises, just flexible tech backed by expert teams. Explore industry-standard solutions: hubs.li/Q03qqH4H0

Accelerate your vaccine research with trial-tested eCOA, RTSM, eConsent, telemedicine, and patient Engagement solutions. With experience in 200+ studies across 30+ countries, we're ready to help bring your vaccine to the public quickly and efficiently. hubs.li/Q03qFDSp0

Pediatric depression #clinicaltrials have challenges: limited sites, variable CDRS-R administration, and complex multi-stakeholder interviews. See how our CDRS-R solution addresses them: hubs.li/Q03qS4BM0 #pediatricdepression

How might placebo response and expectation bias impact #clinicaltrial outcomes? How can they be mitigated to ensure data reliability? Get answers from experts here: hubs.li/Q03rrgfB0

🚀 Our TrialMax® platform features automation for the Data Change Form (DCF) process, reducing manual efforts, minimizing errors, and speeding up data management. Learn how TrialMax® is revolutionizing #eCOA study delivery: hubs.li/Q03rHZXD0

Early detection of cognitive effects can make or break your clinical program. Our CDR system's attention battery identifies cognitive changes in early-phase #clinicaltrials, helping you make confident decisions before costly failures hubs.li/Q03rT4T40

The therapeutic promise of #psychedelic compounds is real, but so are the scientific challenges. Our latest blog reveals evidence-based strategies to maintain methodological rigor and study integrity in psychedelic #clinicaltrials: hubs.li/Q03sfmDD0

Our new "Getting Started with eCOA" series is your go-to resource for mastering the essentials of electronic COAs. Explore our quick-read guides and get the insights you need to succeed. Check it out now: hubs.li/Q03sHcfP0 #ClinicalTrials #eCOA #PatientCentricity

Running GLP-1 RA trials? Our ePRO handles the complexities – from dose escalation tracking and cardiovascular assessments to participant retention. Streamline your data capture and engagement strategy: hubs.li/Q03tmgyq0

How can PRO data help inform optimal dose selection in early-phase #oncology #clinicaltrials? Our new guide makes the case for incorporating patient experience data for a more complete tolerability assessment. Get it here: hubs.li/Q03tyk9c0

When choosing an eClinical partner, biotechs and emerging biopharma shouldn’t have to choose between working with an established, full-service company and a provider with a hands-on approach. Get the best of both worlds: hubs.li/Q03tQxvT0

Signant's ops team has been recognized as a finalist for the OnCon Icon Top 100 Operations Team award. This recognition underscores our commitment to operational excellence as a catalyst for clinical research. Support innovation by voting for us: hubs.li/Q03vtr6S0

Alzheimer’s trials are a maze. Let’s untangle the complexity together. Visit booth 1334 to talk with our team about optimal study design, reducing rater variability, ensuring eligibility, & building more signal-rich dementia trials. See details + posters: hubs.li/Q03vCXg30

Supply shortages derail study timelines and inflate budgets. Our Forecasting & Planning solution enables effective planning to prevent stockouts with real-time usage data and predictive modeling across your entire supply chain.  Protect study timelines: hubs.li/Q03vMzHq0

Complex designs such as adaptive basket or umbrella trials are making RTSM builds more challenging. This blog covers best practices for implementation of adaptive trials: hubs.li/Q03wDz9n0 #RTSM #ClinicalTrials #AdaptiveTrials

At AAIC2025, our clinical science team will present data on screening optimization and endpoint reliability—two critical factors in successful Alzheimer’s disease trial design. Schedule time with our experts or get pre-conference resources: hubs.li/Q03xs13q0

Subjective rating scales may challenge #immunology trials. The fix: electronic assessments with built-in standardization, specialized rater training, and real-time analytics. See this in a PsA trial: hubs.li/Q03xFQzr0 #ClinicalTrials